LEES PHARMACEUTICAL HLDGSLEES PHARMACEUTICAL HLDGSLEES PHARMACEUTICAL HLDGS

LEES PHARMACEUTICAL HLDGS

No trades
See on Supercharts
Market capitalization
‪683.05 M‬HKD
‪16.70 M‬HKD
‪1.05 B‬HKD
‪192.87 M‬
Beta (1Y)
0.50

About LEES PHARMACEUTICAL HLDGS

CEO
Wanee Leelalertsuphakun
Headquarters
Hong Kong
Founded
1994
ISIN
KYG5438W1116
FIGI
BBG000NNJR94
Lee's Pharmaceutical Holdings Ltd. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the Proprietary and Generic Products and Licensed-in Products segments. The Proprietary and Generic Products segment is involved in the manufacturing and sales of self-developed and generic pharmaceutical products. The Licensed-in Products segment focuses on the trading of licensed-in pharmaceutical products. The company was founded by Xiaoyi Li in 1994 and is headquartered in Hong Kong.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 950 is 1.16 HKD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange LEES PHARMACEUTICAL HLDGS stocks are traded under the ticker 950.
LEES PHARMACEUTICAL HLDGS is going to release the next earnings report on Aug 29, 2024. Keep track of upcoming events with our Earnings Calendar.
950 stock is 2.65% volatile and has beta coefficient of 0.50. Check out the list of the most volatile stocks — is LEES PHARMACEUTICAL HLDGS there?
One year price forecast for LEES PHARMACEUTICAL HLDGS has a max estimate of 1.00 HKD and a min estimate of 1.00 HKD.
Yes, you can track LEES PHARMACEUTICAL HLDGS financials in yearly and quarterly reports right on TradingView.
950 stock has risen by 0.87% compared to the previous week, the month change is a 8.66% fall, over the last year LEES PHARMACEUTICAL HLDGS has showed a 22.67% decrease.
Like other stocks, 950 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LEES PHARMACEUTICAL HLDGS stock right from TradingView charts — choose your broker and connect to your account.
950 reached its all-time high on May 26, 2015 with the price of 15.40 HKD, and its all-time low was 1.12 HKD and was reached on Apr 10, 2024.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LEES PHARMACEUTICAL HLDGS technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LEES PHARMACEUTICAL HLDGS stock shows the sell signal. See more of LEES PHARMACEUTICAL HLDGS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on LEES PHARMACEUTICAL HLDGS future price: according to them, 950 price has a max estimate of 1.00 HKD and a min estimate of 1.00 HKD. Read a more detailed LEES PHARMACEUTICAL HLDGS forecast: see what analysts think of LEES PHARMACEUTICAL HLDGS and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LEES PHARMACEUTICAL HLDGS EBITDA is ‪109.82 M‬ HKD, and current EBITDA margin is 10.43%. See more stats in LEES PHARMACEUTICAL HLDGS financial statements.